Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul 18;289(29):19850-4.
doi: 10.1074/jbc.R113.511329. Epub 2014 May 23.

Synthesis of high titer infectious prions with cofactor molecules

Affiliations
Review

Synthesis of high titer infectious prions with cofactor molecules

Surachai Supattapone. J Biol Chem. .

Abstract

Recently, synthetic prions with a high level of specific infectivity have been produced from chemically defined components in vitro. A major insight arising from these studies is that various classes of host-encoded cofactor molecules such as phosphatidylethanolamine and RNA molecules are required to form and maintain the specific conformation of infectious prions. Synthetic mouse prions formed with phosphatidylethanolamine exhibit levels of specific infectivity ∼1 million-fold greater than "protein-only" prions (Deleault, N. R., Walsh, D. J., Piro, J. R., Wang, F., Wang, X., Ma, J., Rees, J. R., and Supattapone, S. (2012) Proc. Natl. Acad. Sci. U.S.A. 109, E1938-E1946). Moreover, cofactor molecules also appear to regulate prion strain properties by limiting the potential conformations of the prion protein (see Deleault et al. above). The production of fully infectious synthetic prions provides new opportunities to study the mechanism of prion infectivity directly by structural and biochemical methods.

Keywords: Cofactor; Infectivity; Phosphatidylethanolamine; Phospholipid; Prion; Protein Misfolding; RNA; Synthetic.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Schematic diagram showing the effect of cofactor withdrawal during serial propagation of purified recombinant PrPSc molecules in vitro. Removal of cofactor from substrate mixture results in PrPSc conformation, as judged by an ∼2-kDa shift in the mobility of the protease-resistant core and ∼106-fold loss of specific infectivity, as judged by end-point dilution bioassay.
FIGURE 2.
FIGURE 2.
Can a single cofactor maintain prion strain diversity? A, hypothetical model illustrating how the existence of multiple cofactor molecules could encipher prion strain diversity. B, schematic diagram showing the experimental paradigm used to test whether a single cofactor (PE) is able to maintain strain diversity. Strain typing assays showed that three different strains converged to form a single, novel strain after in vitro propagation in the presence of PE alone.

References

    1. Deleault N. R., Walsh D. J., Piro J. R., Wang F., Wang X., Ma J., Rees J. R., Supattapone S. (2012) Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc. Natl. Acad. Sci. U.S.A. 109, E1938–E1946 - PMC - PubMed
    1. Prusiner S. B. (1998) Prions. Proc. Natl. Acad. Sci. U.S.A. 95, 13363–13383 - PMC - PubMed
    1. Bruce M. E. (1993) Scrapie strain variation and mutation. Br. Med. Bull 49, 822–838 - PubMed
    1. Carlson G. A. (1996) Prion strains. Curr. Top. Microbiol. Immunol. 207, 35–47 - PubMed
    1. Bessen R. A., Kocisko D. A., Raymond G. J., Nandan S., Lansbury P. T., Caughey B. (1995) Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375, 698–700 - PubMed

Publication types

LinkOut - more resources